Prevention of cervical cancer through papillomavirus vaccination.
about
A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protectionProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsViruses associated with human cancerViruses and human cancerCutaneous squamous cell carcinoma and human papillomavirus: is there an association?HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology.The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.HPV16-E7-Specific Activated CD8 T Cells in E7 Transgenic Skin and Skin Grafts.Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study.Dysregulated expression of long noncoding RNAs in gynecologic cancers.Social values and scientific evidence: the case of the HPV vaccines.A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccine.Cervical cancer cell supernatants induce a phenotypic switch from U937-derived macrophage-activated M1 state into M2-like suppressor phenotype with change in Toll-like receptor profile.HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells.Towards meeting the research needs of Australian cancer consumers.IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).Vaccination against a hit-and-run viral cancer.Towards the eradication of HPV infection through universal specific vaccination.Development of therapeutic HPV vaccines.Production of human papilloma virus type 16 e6 oncoprotein as a recombinant protein in eukaryotic cells.Dietary exposure to brominated flame retardants and abnormal Pap test resultsDoes parents' socio-economic status matter in intentions of vaccinating against human papillomavirus for adolescent daughters?Structural and immunological effects of skin cryoablation in a mouse model.Papillomavirus E5: the smallest oncoprotein with many functions.Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia.Recent developments in human papillomavirus vaccines.Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.Establishment of a cottontail rabbit papillomavirus/HLA-A2.1 transgenic rabbit model.Progress in the development of a cervical cancer vaccine.Vaccines against cervical cancer.Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimensEpithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing CapacityHeat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia IIIEmerging human papillomavirus vaccines.Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion proteinCancer associated human papillomaviruses.Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccineRecent advances in the search for antiviral agents against human papillomaviruses.
P2860
Q21133563-9C64E5E1-34C0-4596-A712-255971AD46A3Q24202048-E389E58A-BD10-4F2F-B500-E57D7D7D9EDEQ24235373-3BB590FC-A920-4BFF-9395-685D52BD2FF8Q24653900-20B94DED-A487-48A1-A63E-924C9957DBA5Q27481175-D8C5779F-9048-46DA-ADFE-4AA8F3C46A97Q27693832-645CDA10-60D9-47CE-9D18-0DC9AAE27C85Q30794549-26F12A26-41B2-4756-8BC6-1383C9469829Q33553561-3FF23508-16B7-4FDB-A757-E1224253A823Q33634022-B6B86252-721C-43E5-9956-DB19A10EC16CQ33787551-34109E06-DDE3-45CB-B894-19763A418F86Q33823613-B555BDF9-74BD-4598-A525-AB77C445259AQ33890189-C499437D-CF93-442D-9337-FEDDE089CA8FQ34121681-4AD4CE0D-5DE9-432E-A3A5-D7CB4E38FCC2Q34260720-8E2C1172-A7ED-4593-B805-BDCB3E4976ADQ34306761-7E139DD1-D64A-45DB-B704-EBFE86E74AB2Q34395881-13948845-63DF-4512-8A79-67762E24FC67Q34498476-EF96D786-6860-459C-9897-F8E7A5D501AAQ34556695-6EF74479-6231-4779-B0E2-0AAD335D04E3Q34641583-A4CAC0B5-E9E1-4CC4-BAB4-B5E87698E52EQ34812959-81D21469-BB76-4FD0-B41A-3F5B448B155FQ34953499-4228C85A-EF51-4F0A-B681-1981BD1EE3B3Q35156193-0A813A2A-A2AA-480D-8059-2FDA05A5E62FQ35202190-C2665872-6645-4A52-8523-5AE8312760D7Q35207380-9063B389-E03D-4430-BD4E-D85314CEAF3BQ35231599-75EAE5D2-BE5D-45BD-93E7-C9834F76A811Q35642759-3211E322-A5E8-40DC-AAB9-1D2B64D4122FQ35737392-22C5F5D8-12DE-425B-AFDC-E0A18734D512Q35842528-0421EA90-4469-4003-BCAC-2E97411DB387Q35901282-804BE030-9487-4641-8C7D-F3D915E34C71Q35914337-B7B3AE34-20C2-4265-905D-B87D32807E50Q35919119-0C91F850-72A2-4D53-8728-BDA31DA34A0CQ35925621-FE32692A-7D71-48B5-82A9-A3BF8FA0D168Q35928124-8CA6063F-2B5F-4D59-8697-7F3EB6D6C776Q35974911-CB21F690-C525-4E01-A12C-109538108FD8Q36052694-FA7AFA03-A204-4824-81AD-1B35E3E2D143Q36066004-409AEF30-C49B-4EB4-84C8-485D86EF727CQ36097148-DA42B7B2-AD34-47AC-A112-D05A5F78E692Q36173879-71721983-8C73-48B0-AAAF-1C5DB4644E23Q36228405-EA16DDD7-9021-4A53-9D71-643FC2AFA5CBQ36284493-BAE51341-72DC-48DC-AE0F-08DFE98577BE
P2860
Prevention of cervical cancer through papillomavirus vaccination.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prevention of cervical cancer through papillomavirus vaccination.
@ast
Prevention of cervical cancer through papillomavirus vaccination.
@en
type
label
Prevention of cervical cancer through papillomavirus vaccination.
@ast
Prevention of cervical cancer through papillomavirus vaccination.
@en
prefLabel
Prevention of cervical cancer through papillomavirus vaccination.
@ast
Prevention of cervical cancer through papillomavirus vaccination.
@en
P356
P1476
Prevention of cervical cancer through papillomavirus vaccination.
@en
P2093
Ian H Frazer
P2888
P356
10.1038/NRI1260
P577
2004-01-01T00:00:00Z
P5875
P6179
1041769980